• Why TrialAssure
  • Products
    • BEACON
    • REGISTRY
    • ANONYMIZE for Data
    • ANONYMIZE for Documents
    • LINK
  • Service Solutions
  • News
  • Resources
    • Transparent Thinking Blog
    • Registry Snapshots
  • Request Free Demo
  • TrialResults
  • Careers
  • Contact Us
TrialAssure
REGISTRY SNAPSHOT: Clinical Trial Register of Singapore

REGISTRY SNAPSHOT: Clinical Trial Register of Singapore

by trialassureadmin | Feb 5, 2019 | Snapshots

REGISTRY SNAPSHOT: Clinical Trial Register of Singapore by Staff writer,Posted on 2/5/2019 Knowing which countries to submit clinical trial results summaries to is the easy part. What becomes difficult is learning the intricacies and transparency requirements of every...
REGISTRY SNAPSHOT: Central Committee on Research Involving Human Subjects (CCMO)

REGISTRY SNAPSHOT: Central Committee on Research Involving Human Subjects (CCMO)

by trialassureadmin | Jan 15, 2019 | Snapshots

REGISTRY SNAPSHOT: Central Committee on Research Involving Human Subjects (CCMO) by Staff writer,Posted on 1/15/2019 Ministry of Health, Welfare and Sport. Hague, the Netherlands. Knowing what countries to submit clinical trial results summaries to is the easy part....
Questions answered on FDA’s draft guidance on civil money penalties for ClinicalTrials.gov

Questions answered on FDA’s draft guidance on civil money penalties for ClinicalTrials.gov

by trialassureadmin | Oct 2, 2018 | Blog

Questions answered on FDA’s draft guidance on civil money penalties for ClinicalTrials.gov by Staff writer,Posted on 10/2/2018 The FDA issued a draft guidance in September 2018 to detail the regulatory body’s thinking on monetary penalties of up to $10,000 per day for...
VIDEO: Clinical Trial Disclosures; More Transparency in the Future

VIDEO: Clinical Trial Disclosures; More Transparency in the Future

by trialassureadmin | Jul 7, 2013 | Blog

VIDEO: Clinical Trial Disclosures; More Transparency in the Future by Joe Archer, Associate Director of Trial Disclosure ServicesPosted on 7/7/2013 Ed Miseta, Editor of Clinical Leader, interviews Joe Archer, Associate Director of Trial Disclosure Services at DIA...
Clinical Trial Disclosure: More “FDA” Needed in Past and Present Acts

Clinical Trial Disclosure: More “FDA” Needed in Past and Present Acts

by trialassureadmin | Nov 29, 2012 | Blog

  Clinical Trial Disclosure: More “FDA” Needed in Past and Present Acts by Joe Archer, Associate Director of Trial Disclosure ServicesPosted on 11/29/2012 Federal mandates calling for transparency of clinical trial information have been in place in the United States...
« Older Entries

Recent Posts

  • This week in transparency news: December 19, 2020 – January 8, 2021
  • Lay Summary Whitepaper
  • This week in transparency news: December 5 – December 18, 2020
  • This week in transparency news: November 21 – December 4, 2020
  • This week in transparency news: November 7 – November 20, 2020

Tags

Anonymization ANZCTR blockchain Brazilian Clinical Trials Registry brexit Chinese Clinical Trial Registry Clincal Trial Data clinical data Clinical Disclosure Reporting Clinical Research Information Service Clinical Study Reports Clinical Trial Clinical Trial Disclosure clinical trial registration clinical trial reporting clinical trials ClinicalTrials.gov Clinical Trials and Submissions Data Clinical Trials Information Management process Clinical Trials Transparency Clinical Trial Transparency Compliance Data Sharing Disclosure of Clinical Trial Results EMA EUCTR EudraCT FDA FDAAA FDAMA Final Rule Global Registries Good Pharma Scorecard health canada ICMJE Lay Summaries open science movement Redaction Registration and Results Reporting Sunshine Act Transparency Transparency News TrialAssure News Trial Disclosure World Health Organization
© Copyright TrialAssure. All rights reserved.